JP2018528948A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018528948A5 JP2018528948A5 JP2018510724A JP2018510724A JP2018528948A5 JP 2018528948 A5 JP2018528948 A5 JP 2018528948A5 JP 2018510724 A JP2018510724 A JP 2018510724A JP 2018510724 A JP2018510724 A JP 2018510724A JP 2018528948 A5 JP2018528948 A5 JP 2018528948A5
- Authority
- JP
- Japan
- Prior art keywords
- apremilast
- toluene
- mixture
- acetic acid
- isolated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562211280P | 2015-08-28 | 2015-08-28 | |
| US62/211,280 | 2015-08-28 | ||
| US201662279147P | 2016-01-15 | 2016-01-15 | |
| US62/279,147 | 2016-01-15 | ||
| PCT/SG2016/050413 WO2017039537A1 (en) | 2015-08-28 | 2016-08-25 | Novel forms of apremilast and the process of making the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018528948A JP2018528948A (ja) | 2018-10-04 |
| JP2018528948A5 true JP2018528948A5 (enExample) | 2019-08-29 |
Family
ID=58097541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018510724A Pending JP2018528948A (ja) | 2015-08-28 | 2016-08-25 | アプレミラストの新規形態及びその作成方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9765026B2 (enExample) |
| EP (1) | EP3341360A4 (enExample) |
| JP (1) | JP2018528948A (enExample) |
| KR (1) | KR20180036791A (enExample) |
| CN (1) | CN107922332A (enExample) |
| CA (1) | CA2994217A1 (enExample) |
| IL (1) | IL257195A (enExample) |
| TW (1) | TWI613191B (enExample) |
| WO (1) | WO2017039537A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016174685A1 (en) * | 2015-04-27 | 2016-11-03 | Mylan Laboratories Limited | Process for the enantiomeric resolution of apremilast intermediates |
| US10544097B2 (en) * | 2015-08-27 | 2020-01-28 | Msn Laboratories Private Limited | Solid state forms of N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]acetamide and process for preparation thereof |
| CN106977444B (zh) * | 2016-01-18 | 2021-10-08 | 重庆医药工业研究院有限责任公司 | 一种阿普斯特无定型的制备方法 |
| MY193175A (en) * | 2016-03-30 | 2022-09-26 | Sarudbhava Formulations Private Ltd | Apremilast pharmaceutical compositions |
| CN107686461A (zh) * | 2016-08-04 | 2018-02-13 | 广东东阳光药业有限公司 | 阿普斯特的溶剂化物及其制备方法和用途 |
| WO2019021303A1 (en) * | 2017-07-23 | 2019-01-31 | Alkem Laboratories Limited | NOVEL PROCESS FOR THE PREPARATION OF APREMILAST IN AMORPHOUS FORM |
| CN108440381A (zh) * | 2018-03-15 | 2018-08-24 | 威海迪素制药有限公司 | 一种阿普斯特新晶型h及其制备方法 |
| US12351555B2 (en) | 2021-04-26 | 2025-07-08 | Amgen Inc. | Process for synthesizing apremilast |
| JPWO2023120466A1 (enExample) * | 2021-12-23 | 2023-06-29 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8093293B2 (en) | 1998-07-06 | 2012-01-10 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin conditions |
| US7893101B2 (en) | 2002-03-20 | 2011-02-22 | Celgene Corporation | Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof |
| US6962940B2 (en) | 2002-03-20 | 2005-11-08 | Celgene Corporation | (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| CA2627892A1 (en) * | 2005-11-01 | 2007-05-10 | Janssen Pharmaceutica N.V. | Substituted dihydroisoindolones as allosteric modulators of glucokinase |
| DK2276483T3 (da) * | 2008-03-27 | 2014-06-10 | Celgene Corp | Faste former, omfattende (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindolin-1,3-dion, sammensætninger deraf og anvendelser deraf |
| KR101514866B1 (ko) * | 2009-05-14 | 2015-04-24 | 티안진 헤메이 바이오-텍 컴퍼니 리미티드 | 티오펜 유도체 |
| AP2013007331A0 (en) * | 2011-06-24 | 2013-12-31 | Amgen Inc | TRPM8 antagonists and their use in treatments |
| US8981117B2 (en) | 2012-09-14 | 2015-03-17 | Celgene Corporation | Processes for the preparation of isoindole compounds and isotopologues thereof |
| UY35103A (es) * | 2012-10-29 | 2014-05-30 | Glaxo Group Ltd | Compuestos de cefem 2-sustituidos |
| EP2730278A1 (en) * | 2012-11-08 | 2014-05-14 | Ratiopharm GmbH | Composition melt |
| IN2014MU01283A (enExample) | 2014-04-04 | 2015-10-09 | Cadila Healthcare Ltd | |
| CN104447445B (zh) | 2014-12-05 | 2016-07-06 | 新发药业有限公司 | 一种合成阿普斯特中间体的制备方法 |
| BR112017025262A2 (pt) | 2015-05-26 | 2018-07-31 | Lupin Ltd | processo aperfeiçoado para preparação de apremilast e seus novos polimorfos |
| MX2017016054A (es) * | 2015-06-09 | 2018-04-11 | Dr Reddys Laboratories Ltd | Proceso para la preparacion de apremilast y sus intermedios. |
-
2016
- 2016-08-24 US US15/246,392 patent/US9765026B2/en active Active
- 2016-08-25 EP EP16842429.9A patent/EP3341360A4/en not_active Withdrawn
- 2016-08-25 JP JP2018510724A patent/JP2018528948A/ja active Pending
- 2016-08-25 KR KR1020187008651A patent/KR20180036791A/ko not_active Ceased
- 2016-08-25 CN CN201680050410.4A patent/CN107922332A/zh active Pending
- 2016-08-25 WO PCT/SG2016/050413 patent/WO2017039537A1/en not_active Ceased
- 2016-08-25 CA CA2994217A patent/CA2994217A1/en not_active Abandoned
- 2016-08-26 TW TW105127548A patent/TWI613191B/zh active
-
2018
- 2018-01-28 IL IL257195A patent/IL257195A/en unknown